The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.

Disclosures: Todd J Schwedt, MD, MSCI Grant/Research/Clinical Trial Support: Merck, Inc (Migraine [rizatriptan).Consultant/Advisory Boards: Allergan (Migraine [onabotulinumtoxinA]); Pfizer (migraine [eletriptan]); MAP (Migraine [inhaled dihydroergotamine]); Zogenix (Migraine [sumatriptan needle free injection]); Supernus (migraine [topiramate extended release]). David W Dodick, MD Consultant/Advisory Boards: Allergan; Alder; Amgen; Pfizer; Merck; ENeura; NuPathe; Eli Lilly & Company; Colucid; Autonomic Technologies; Zogenix; Bristol Myers Squibb; Arteaus; Ethicon – Johnson & Johnson (headache). Jerry W Swanson, MD Nothing to disclose. John F Dashe, MD, PhD Employee of UpToDate, Inc.

Contributor disclosures are reviewed for conflicts of interest by the editorial group. When found, these are addressed by vetting through a multi-level review process, and through requirements for references to be provided to support the content. Appropriately referenced content is required of all authors and must conform to UpToDate standards of evidence.

Conflict of interest policy

All topics are updated as new evidence becomes available and our peer review process is complete.
Literature review current through: Mar 2014. | This topic last updated: Nov 20, 2013.

INTRODUCTION AND DEFINITION — Thunderclap headache (TCH) refers to a severe headache of sudden onset. Its explosive and unexpected nature is likened to a "clap of thunder." Although TCH initially referred to pain associated with an unruptured intracranial aneurysm [1], multiple etiologies are now recognized [2] (table 1). These include cerebral venous thrombosis, cervical artery dissection, spontaneous intracranial hypotension, pituitary apoplexy, retroclival hematoma, ischemic stroke, acute hypertensive crisis with reversible posterior leukoencephalopathy syndrome, third ventricular colloid cysts, bacterial and viral meningitis, complicated sinusitis, and reversible cerebral vasoconstriction syndromes.

In addition, the term primary TCH is often used to refer to a benign, idiopathic, and potentially recurrent headache of sudden and severe intensity with a lack of underlying pathology.

This topic will review each of the entities considered in patients with TCH, offer pathophysiologic considerations, and discuss the diagnostic evaluation of TCH.

DIFFERENTIAL DIAGNOSIS — In addition to the pain associated with the onset of subarachnoid hemorrhage from intracranial aneurysm rupture, thunderclap headache may be associated with multiple other causes (table 1).

Reversible cerebral vasoconstriction syndromes

Sentinel headache

Cerebral venous thrombosis

Cervical artery dissection

Spontaneous intracranial hypotension

Pituitary apoplexy

Retroclival hematoma

Ischemic stroke

Acute hypertensive crisis

Colloid cyst of the third ventricle


Primary thunderclap headache

These are discussed in greater detail in the following sections.

Other conditions that may rarely present with TCH include the following:

Acute myocardial infarction [3]

Anaplastic oligodendroglioma [4]

Aqueductal stenosis [5]

Pheochromocytoma [6,7]

Vogt-Koyanagi-Harada syndrome [8]

Subarachnoid hemorrhage — The primary symptom of aneurysmal subarachnoid hemorrhage is a sudden, severe headache. While there are no symptoms or signs that can reliably differentiate primary from secondary TCH, the following features are associated with increased odds of subarachnoid hemorrhage in a patient with TCH [9-11]:

Impaired consciousness

Neck stiffness

Nausea, vomiting

Exertion or Valsalva immediately preceding onset of TCH

Elevated blood pressure

Occipital headache

History of smoking

Whether or not these features are present, all patients with TCH need to be evaluated for subarachnoid hemorrhage and other underlying causes (see 'Diagnostic evaluation' below). Approximately 12 to 51 percent of patients with subarachnoid hemorrhage are initially misdiagnosed [12,13]. Misdiagnosis occurs because of failure to recognize the spectrum of possible presentations of subarachnoid hemorrhage, lack of knowledge regarding the limitations of head CT, and failure to perform lumbar puncture and interpret cerebrospinal fluid tests correctly. (See "Clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage", section on 'Diagnosis of subarachnoid hemorrhage'.)

Initial evaluation for subarachnoid hemorrhage must include noncontrast CT of the brain. Lumbar puncture is indicated when there is clinical suspicion of subarachnoid hemorrhage and the head CT is normal (algorithm 1).

The diagnosis of subarachnoid hemorrhage as well as the utility of head CT and lumbar puncture are discussed in greater detail separately. (See "Clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage", section on 'Diagnosis of subarachnoid hemorrhage' and 'Diagnostic evaluation' below.)

Sentinel headache — Ten to 43 percent of patients with aneurysmal subarachnoid hemorrhage report a history of a sentinel or warning headache [14]. A sentinel headache is an episode of headache similar to that accompanying subarachnoid hemorrhage but occurring days to weeks prior to aneurysm rupture. Sentinel headaches are likely caused by small aneurysmal leaks of blood into the subarachnoid space or physical changes within the aneurysm wall. Sentinel headaches develop over seconds, reach maximal intensity within minutes, and may endure for hours to days. Features of subarachnoid hemorrhage, including stiff neck, altered consciousness, and focal neurologic symptoms and signs are usually absent. (See "Clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage", section on 'Clinical presentation'.)

It is essential to recognize TCH as a possible warning of aneurysm rupture. In patients in which aneurysms are found, and subarachnoid hemorrhage is documented, surgical or endovascular intervention, as indicated, may result in avoidance of the catastrophic event. (See "Treatment of aneurysmal subarachnoid hemorrhage" and "Unruptured intracranial aneurysms".)

However, sentinel headaches are often ignored by both patients and clinicians or are misdiagnosed.

Reversible cerebral vasoconstriction syndromes — Conditions associated with TCH and diffuse, segmental, reversible cerebral vasospasm are referred to as reversible cerebral vasoconstriction syndromes (RCVS) [15,16]. This disorder has been described throughout the literature in the past using various eponymous or syndromic classifications, including the following [15,17-21]:

Thunderclap headache with vasospasm

Benign angiopathy of the central nervous system (BACNS)

Migrainous vasospasm or crash migraine

Call-Fleming syndrome (or Call syndrome)

Postpartum angiopathy

Drug-induced cerebral vasoconstriction

Thus, RCVS may occur in patients who have a history of migraine, in the postpartum period, and in those exposed to different pharmacologic agents, including ergotamine, triptans, selective serotonin reuptake inhibitors, pseudoephedrine, cocaine, amphetamines, ecstasy, cannabis, and bromocriptine [22-31].

Patients with RCVS present with TCH (often with recurrent TCH over several days to weeks), normal or near-normal cerebrospinal fluid, and reversible cerebral segmental vasospasm involving arteries of the circle of Willis. Thunderclap headache may occur in isolation or in conjunction with other symptoms, such as altered mental status, motor deficits, sensory deficits, seizures, visual changes, ataxia, speech abnormalities, and nausea/vomiting.

Angiographically, RCVS manifest as alternating segments of vasoconstriction and dilation or alternating areas of vasoconstriction and normal vascular caliber in the proximal and distal branches of the circle of Willis. Brain MRI may be normal or have abnormalities consistent with infarction (often posterior and borderzone/watershed), posterior reversible encephalopathy syndrome (PRES), convexity subarachnoid hemorrhage, lobar hemorrhage, or less commonly, subdural hemorrhage [32,33].

Diagnostic criteria for RCVS have not been validated, but key elements for confirming the diagnosis include all of the following features [15,16]:

Severe acute headaches with or without additional neurologic symptoms or signs

No evidence of aneurysmal subarachnoid hemorrhage

Multifocal segmental cerebral artery vasoconstriction by contrast angiography or CTA or MRA

Normal or mildly abnormal cerebrospinal fluid (CSF) analysis (ie, CSF protein <100 mg/dL, CSF leukocyte count <15 cells/microL, and normal CSF glucose)

Reversibility of angiographic vasoconstriction within three months of onset

In the majority of cases, RCVS is self-limiting. However, patients may have fluctuating focal neurologic symptoms and signs, including seizures and strokes. (See "Headache, migraine, and stroke", section on 'Reversible cerebral vasoconstriction syndromes'.)

There are conflicting data regarding the utility of calcium-channel blockers for the treatment of RCVS [32,34-39]. Complete normalization or significant improvement in vasospasm, even in the absence of specific treatment, is expected within 12 weeks of symptom onset.

Cerebral venous thrombosis — Patients with cerebral venous thrombosis may present with TCH. Headache is the most common presenting symptom in cerebral venous thrombosis, occurring in approximately 90 percent of patients. In addition to headaches, patients with cerebral venous thrombosis usually present with some combination of papilledema, seizures, bilateral focal deficits, and/or altered level of consciousness. However, about 15 percent of patients may present with isolated headache. (See "Etiology, clinical features, and diagnosis of cerebral venous thrombosis", section on 'Headache'.)

Thunderclap headache is the main symptom of cerebral venous thrombosis in 2 to 13 percent of patients, as suggested by the following reports:

A retrospective analysis of 48 patients with cerebral venous thrombosis reported six (13 percent) who presented with TCH [40]

A prospective study of 123 consecutive patients with cerebral venous thrombosis found that isolated headache was the only sign in 17 (14 percent), and that TCH was the presenting sign in three (2.4 percent) [41].

Most commonly, however, the headaches of cerebral venous thrombosis have a gradual subacute onset; they may be localized or diffuse, persistent, exacerbated by Valsalva, and positional with worsening on recumbency.

In cases of cerebral venous thrombosis associated with TCH, the initial presentation of cerebral venous thrombosis may be clinically indistinguishable from that of subarachnoid hemorrhage. Magnetic resonance imaging (MRI) with venography should be considered when cerebral venous thrombosis is suspected, as initial testing for a suspected diagnosis of subarachnoid hemorrhage with head CT and lumbar puncture will not always detect cerebral venous thrombosis. In patients with cerebral venous thrombosis who have normal neurologic exams, the head CT is normal in approximately 25 percent, whereas in patients with cerebral venous thrombosis who have focal neurologic signs, the head CT is normal in less than 10 percent [42,43]. (See "Etiology, clinical features, and diagnosis of cerebral venous thrombosis", section on 'Diagnosis'.)

Cervical artery dissection — Headache and/or neck pain is the most frequent initial symptom of cervicocephalic dissection, found in 60 to 90 percent of cases. (See "Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis", section on 'Local symptoms'.)

Although the onset of headache in cervical artery dissection is usually gradual, a sudden and severe onset of pain consistent with a TCH occurs in approximately 20 percent of patients [44,45]. International Headache Society (IHS) diagnostic criteria for headache secondary to cervical artery dissection stipulate that the headache must be ipsilateral to the dissected artery [46].

Cervical artery dissection can cause ischemic stroke, transient ischemic attack, or rarely, subarachnoid hemorrhage. In addition to neck pain and headache, other local manifestations of dissection can include a Horner syndrome, pulsatile tinnitus, an audible bruit, or cranial neuropathies. Common causes of dissection include various degrees of trauma or spontaneous events, with underlying predispositions in some cases. Dissection can also result from major head and neck trauma, but most dissections occur spontaneously or after minor or trivial injury. (See "Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis", section on 'Etiology'.)

In the absence of ischemic stroke, routine CT scanning of the brain and lumbar puncture are typically unrevealing in patients with dissection. Additional diagnostic tests are necessary if there is clinical suspicion for cervical artery dissection; these could include ultrasound, CT angiography, magnetic resonance angiography, conventional angiography, or MRI of the neck with a fat saturation protocol. The diagnosis is confirmed by neuroimaging findings, particularly the demonstration of a long tapered arterial stenosis, a tapered occlusion, a dissecting aneurysm (pseudoaneurysm), an intimal flap, a double lumen, or an intramural hematoma. (See "Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis", section on 'Neuroimaging'.)

The management of cervicocephalic dissection is reviewed elsewhere. (See "Spontaneous cerebral and cervical artery dissection: Treatment and prognosis".)

Spontaneous intracranial hypotension — Patients with spontaneous intracranial hypotension (SIH) usually present with orthostatic headaches and some combination of nausea/vomiting, dizziness, auditory changes, diplopia, visual blurring, interscapular pain, and/or upper extremity radicular pain. This syndrome is also known as spontaneous low cerebrospinal fluid pressure headache.

Cerebrospinal fluid (CSF) leakage from spinal meningeal defects or dural tears may be the most common causes of this syndrome [47]. The headache is caused by displacement of pain-sensitive structures due to the low CSF pressure. (See "Headache attributed to spontaneous intracranial hypotension: Pathophysiology, clinical features, and diagnosis".)

A minority of patients with low CSF pressure headache will present with TCH. In a series of 28 patients with low CSF pressure headache due to CSF leaks from dural tears, TCH was the presenting sign in 4 patients (14 percent) [48]. Evaluation for subarachnoid hemorrhage, including CT scan, lumbar puncture, and cerebral angiography, was nondiagnostic. However, each patient had features of low CSF pressure on brain MRI, including either brain or cerebellar tonsillar descent, and diffuse pachymeningeal gadolinium enhancement.

Pituitary apoplexy — TCH may be the predominant feature of pituitary apoplexy. Pituitary apoplexy usually presents with a combination of acute headache, ophthalmoplegia, decreased visual acuity, and change in mental status. It is caused by hemorrhage or infarction of the pituitary gland in the setting of a pituitary adenoma. The clinical presentation of pituitary apoplexy ranges from relatively mild symptoms to adrenal crisis, coma, or even sudden death.

Pituitary apoplexy can present with TCH in patients who have normal physical examinations, head CT scans, and cerebrospinal fluid analyses [49,50]. Pituitary tumors that are isodense to normal brain tissue may be easily overlooked on CT studies, even if hemorrhage is present. Brain MRI has a much higher sensitivity than CT for detecting the tumor and associated blood.

Retroclival hematoma — Spontaneous retroclival hematomas may present as TCH [51]. Retroclival hematomas are usually seen as a rare manifestation of severe head and neck injuries in which there is atlantoaxial dislocation. However, spontaneous hemorrhage can occur. Evidence for this comes from a case report of a 49-year-old woman who developed an instantaneous excruciating headache [51]. She had a normal neurologic examination and normal CT scan of the brain, but cerebrospinal fluid analysis revealed xanthochromia and MRI of the cervical spine revealed the retroclival hematoma. This case reinforces the recommendation to consider MRI in patients presenting with TCH in which initial tests are nondiagnostic.

Ischemic stroke — TCH may rarely be the presenting feature of ischemic stroke. Approximately 25 to 34 percent of patients with stroke develop an associated headache [52,53]. In about 50 percent of those who develop headache with stroke, the headache occurs prior to other stroke manifestations. In patients with a history of a primary headache disorder, the headache developing in association with stroke may resemble their usual headache. In others, a throbbing headache ipsilateral to the side of the stroke is most common [53]. (See "Headache, migraine, and stroke".)

In most cases, headaches associated with stroke are not consistent with TCH. However, several cases of ischemic stroke associated with TCH have been reported, including cases in which TCH was the primary clinical feature [9,54-56]. CT and lumbar puncture may be nondiagnostic in patients with TCH and recent stroke, suggesting the necessity of MRI in such cases.

Acute hypertensive crisis — TCH may be a presenting feature of acute hypertensive crisis and reversible posterior leukoencephalopathy syndrome (RPLS). Two such cases have been reported in the literature. In one case report, a patient presented with hypertension, TCH, and white matter abnormalities on MRI involving the parieto-occipital regions consistent with RPLS [57]. In the second case, the patient had recurrent thunderclap headaches and a generalized tonic-clonic seizure [58]. Angiography revealed diffuse, multifocal, segmental vasospasm involving the arteries of the circle of Willis and its branches.

Although headaches occur in approximately 20 percent of patients with hypertensive crisis, they are most often described as throbbing and indistinct [59]. Other manifestations of hypertensive crisis include faintness, dyspnea, chest pain, psychomotor agitation, focal neurologic deficits, and epistaxis.

In the presence of RPLS, patients may have nausea and vomiting, visual changes, altered mental status, seizures, and focal neurologic signs [60,61]. Consideration of acute hypertensive crisis and RPLS as a possible cause of TCH is important for accurate diagnosis. Most commonly, hypertension in the setting of a TCH may arise as a stress response.

Evaluation for underlying subarachnoid hemorrhage with head CT and lumbar puncture may miss the diagnosis of RPLS. MRI is more sensitive than head CT for revealing the white matter and cortical edema associated with RPLS. These changes typically involve the parietal and occipital lobes and may also involve the basal ganglia, brainstem, and cerebellum [62]. Since the imaging changes are secondary to vasogenic edema and not ischemia or infarction, prompt treatment of the hypertension is essential and should result in correction of the associated clinical syndrome [63].

The pathogenesis, clinical features, diagnosis, neuroimaging and treatment of RPLS is discussed in greater detail separately. (See "Reversible posterior leukoencephalopathy syndrome".)

Colloid cyst of the third ventricle — Patients with colloid cysts of the third ventricle may also present with TCH when the cyst, which can act like a ball valve, suddenly impedes the flow of cerebrospinal fluid, causing acute obstructive hydrocephalus. Headache is reported by 68 to 100 percent of patients with third ventricular colloid cysts, making it the most commonly associated symptom.

Typically, the headache has an acute onset and resolution, with a duration of seconds to one day [64]. The pain is often severe and may be relieved by taking the supine position. Headaches may be located in the bilateral frontal, fronto-parietal, or fronto-occipital head regions [65]. Approximately one-half of patients have associated nausea and vomiting. Loss of consciousness, mental status changes, seizures, coma, and death can occur [66].

Third ventricular colloid cysts are diagnosed via CT or MRI of the brain.

Infections — Bacterial and viral meningitis are most commonly associated with headaches of a gradual onset, but may rarely present with TCH. A prospective analysis of 148 patients presenting to their primary care physician with TCH found four (2.7 percent) with infectious etiologies [67]. Lumbar puncture for cerebrospinal fluid examination is required for diagnosis.

Headaches related to acute sinusitis may also rarely be of the thunderclap variety. Although headaches and facial pain are frequent in patients with acute rhinosinusitis, most commonly these are acute to subacute in presentation and not consistent with TCH. However, TCH may occasionally be the presenting manifestation of sinusitis when related intracranial complications have occurred, such as with extension through the sphenoid sinus [68].

Primary thunderclap headache — TCH may occur as a benign and potentially recurrent headache disorder in the absence of underlying organic intracranial pathology. However, it cannot be overstated that primary TCH must be a diagnosis made only after exclusion of all possible underlying causes [69,70].

Current diagnostic criteria for primary thunderclap headache from the International Classification of Headache Disorders 3rd edition (ICHD-3) require fulfilling the following criteria [70]:

Severe head pain

Abrupt onset, reaching maximum intensity in <1 minute

Lasting for ≥5 minutes

Not better accounted for by another ICHD-3 diagnosis

In addition, the diagnosis requires normal brain imaging, including the brain vessels, and/or normal cerebrospinal fluid findings [70].

Primary TCH may occur spontaneously, while a patient is at rest, or may be precipitated by exertion or Valsalva. Exercise, weight lifting, or sexual activity is a precipitating event in up to one-third of cases.

PATHOPHYSIOLOGY — The underlying pathophysiology of primary thunderclap headache (TCH) and reversible cerebral vasoconstriction syndromes (RCVS) is unclear. Excessive sympathetic activity or an abnormal vascular response to circulating catecholamines may be involved. This would explain the occurrence of TCH during physical activity, in patients with pheochromocytoma, acute hypertensive crises, and in patients who take sympathomimetic drugs or tyramine containing foods concurrently with MAO inhibitors. In further support of this hypothesis, reversible cerebral vasospasm has been documented in pheochromocytoma, eclampsia, sympathomimetic drug intoxication, and autonomic dysreflexia [71-75].

Although vasospasm can be initiated by mechanical, biochemical, and neurogenic stimuli, the abrupt onset of headache and vasospasm implies a neurogenic mechanism. Sympathetic afferents that innervate the intracranial vasculature contain neuropeptide Y and noradrenaline, both vasoconstrictors [76,77]. Vascular caliber may be a reflection of sympathetic tone and sympathetic receptor sensitivity, and primary TCH may be a result of spontaneous and abnormal central sympathetic response. This theory is supported by models of vasospasm in subarachnoid hemorrhage as well as the clinical finding of multifocal vasospasm in patients with pheochromocytoma and sympathomimetic drug intoxication [71,73,74,78,79].

DIAGNOSTIC EVALUATION — Given the potentially serious nature of possible underlying intracranial etiologies, TCH must be considered and treated as a medical emergency. Since several of the underlying causes of TCH are associated with significant morbidity and mortality, the clinician must initially presume that the patient presenting with TCH has a secondary TCH. Only after a comprehensive evaluation for underlying causes is negative should the diagnosis of primary TCH be considered.

Evaluation for subarachnoid hemorrhage — Initial testing (algorithm 1) focuses on evaluation for subarachnoid hemorrhage (SAH). Brain CT without contrast, the first test in this evaluation, is highly sensitive and specific for the diagnosis of SAH within the first 12 to 24 hours. During the first 12 hours following onset of headache, third-generation CT scanners have a sensitivity nearing 100 percent and a specificity of 98 percent [12]. However, these numbers are based upon studies that used expert neuroradiologists to interpret the scans.

In general practice, clinicians may easily overlook subtle imaging abnormalities suggestive of SAH. In addition, the sensitivity of head CT in SAH declines rapidly over time, decreasing to 86 percent on day two, 76 percent after two days, and 58 percent after five days [80]. Therefore, lumbar puncture is required in the evaluation of patients presenting with TCH who have CT scans interpreted as normal or inadequate. Lumbar puncture should include measurement of opening pressure (which may be elevated in patients with SAH or cerebral venous thrombosis), routine cerebrospinal fluid (CSF) analyses including cell counts, and visual inspection for xanthochromia.

Some experts recommend the use of CSF spectrophotometry, if available, to measure xanthochromia, especially when a traumatic tap makes CSF interpretation difficult or when the specimen has been improperly processed. The sensitivity of spectrophotometry approaches 100 percent when lumbar puncture is performed 12 hours to two weeks after SAH onset [81]. Despite its high sensitivity, spectrophotometry has only low to moderate specificity for the diagnosis of SAH and is not universally recommended. As a practical matter, spectrophotometry is rarely available in North American hospitals. (See "Clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage", section on 'Lumbar puncture'.)

The necessity of performing conventional angiography to evaluate for unruptured intracranial aneurysms in patients with TCH who have normal neurologic exams, normal head CT, and normal lumbar puncture is still debatable [82,83]. However, the bulk of evidence suggests that conventional angiography is not necessary in this setting [84]. In a retrospective study of 71 patients with TCH and normal CT and lumbar puncture, none had SAH during an average follow-up of 3.3 years [85]. Prospective analyses have had similar results. Among a total of 225 patients with primary TCH in four prospective studies, no patient had SAH or sudden death during at least one year of follow-up [10,86-88]. In addition, conventional angiography carries a small but real risk of transient and permanent neurologic complications (1 and 0.5 percent respectively). This risk may be higher in patients with TCH, especially if they have associated vasospasm [89,90].

Magnetic resonance angiography (MRA) or CT angiography (CTA) may be considered in patients who have nondiagnostic CSF studies when spectrophotometry is not available, or when the index of suspicion for intracranial aneurysm is very high. The sensitivity of MRA ranges from 69 to 100 percent and is dependent upon the size of the aneurysm [91]. For aneurysms 6 mm or larger, MRA sensitivity is greater than 95 percent. Although CTA has been studied less extensively, it has an overall detection rate of 85 to 98 percent [92,93]. CTA requires patient exposure to radiation and carries a small risk of allergic reaction to contrast material and deterioration of renal function.

Evaluation for other causes — The exact role of brain MRI in the evaluation of TCH has not yet been defined, but MRI is more sensitive than head CT for many of the possible underlying causes of TCH, such as cerebral venous thrombosis, cervical artery dissection, spontaneous intracranial hypotension, and reversible posterior leukoencephalopathy syndrome.

Therefore, for patients with TCH who have a negative work-up for subarachnoid hemorrhage (ie, a nondiagnostic head CT and lumbar puncture), we suggest obtaining brain MRI and imaging of the cerebral vasculature with MR angiography and MR venography. If MR imaging is not an option, we suggest imaging the cerebral vasculature with CT angiography and CT venography.

Likelihood of identifying an underlying cause — An underlying cause for TCH is identified in 27 to 71 percent of patients [9,11,67,87]. The wide range of these findings is attributable to the use of different criteria for defining and diagnosing TCH among the various studies, and to the inclusion of patients from variable settings (eg, emergency room versus outpatient). While all of the cited studies used brain CT and lumbar puncture for diagnosis, angiography was either not used or was used sparingly. This may have led to missed diagnoses of certain conditions, such as the reversible cerebral vasoconstriction syndromes, and to underestimation of secondary TCH frequency.

Subarachnoid hemorrhage is consistently the most frequent cause for TCH in these series [9,11,67,87]. Other vascular conditions (ie, cervical artery dissection, cerebral venous thrombosis, and reversible cerebral vasoconstriction syndromes) are the next most frequent secondary causes of TCH; these disorders can present with TCH in isolation [2,94]. Supporting evidence comes from a series of 56 consecutive patients with recurrent thunderclap headache of unknown etiology, including no evidence of subarachnoid hemorrhage on both CT head and cerebrospinal fluid examination, who were referred to a headache clinic in Taiwan [38]. Magnetic resonance angiography (MRA) performed at a mean interval of 11 days after the first headache attack showed segmental vasoconstriction involving Circle of Willis vessels in 39 percent (see 'Reversible cerebral vasoconstriction syndromes' above). This finding must be interpreted cautiously, since the utility of MRA for determination of segmental vasoconstriction is not established. Nevertheless, this report illustrates the potential for serious causes of TCH other than subarachnoid hemorrhage and the importance of a thorough investigation, including vascular imaging of the extracranial and intracranial circulation, in all patients presenting with TCH who have no evidence of subarachnoid hemorrhage.

MANAGEMENT — The management of TCH depends on the underlying etiology. This is discussed separately for the following conditions:

Cerebral aneurysm (see "Treatment of aneurysmal subarachnoid hemorrhage" and "Unruptured intracranial aneurysms")

Cerebral venous thrombosis (see "Treatment and prognosis of cerebral venous thrombosis")

Spontaneous low cerebrospinal fluid pressure headache (see "Headache attributed to spontaneous intracranial hypotension: Treatment and prognosis")

Cervical artery dissection (see "Spontaneous cerebral and cervical artery dissection: Treatment and prognosis")

Ischemic stroke (see "Initial assessment and management of acute stroke" and "Initial evaluation and management of transient ischemic attack and minor stroke")

Acute hypertensive crisis (see "Drug treatment of hypertensive emergencies" and "Malignant hypertension and hypertensive encephalopathy in adults" and "Reversible posterior leukoencephalopathy syndrome", section on 'Prevention and treatment')


Thunderclap headache (TCH) refers to a severe headache of sudden onset. (See 'Introduction and definition' above.)

Thunderclap headache requires urgent evaluation as such headaches may be harbingers of subarachnoid hemorrhage. However, a wide range of different etiologies must be considered when evaluating a patient with TCH (table 1). These include unruptured intracranial aneurysm, cerebral venous thrombosis, cervical artery dissection, spontaneous intracranial hypotension, pituitary apoplexy, retroclival hematoma, acute hypertensive crisis, third ventricular colloid cysts, viral and bacterial meningitis, acute complicated sinusitis, reversible cerebral vasoconstriction syndromes, and primary thunderclap headache. (See 'Differential diagnosis' above.)

Primary TCH is a diagnosis that should be made only after exclusion of all other possible underlying causes. A comprehensive evaluation for underlying pathology must be performed prior to diagnosis of primary TCH. (See 'Primary thunderclap headache' above.)

The underlying pathophysiology of TCH with or without vasospasm is unclear. Excessive sympathetic activity or an abnormal vascular response to circulating catecholamines may be involved. (See 'Pathophysiology' above.)

For all patients with TCH, we recommend head CT and, if head CT is normal, lumbar puncture with measurement of opening pressure and cerebrospinal fluid analysis (algorithm 1). For patients with TCH who have nondiagnostic head CT and lumbar puncture, imaging of the cerebral circulation is necessary. We suggest obtaining brain MRI and noninvasive neurovascular imaging such as MR or CT angiography/venography. (See 'Diagnostic evaluation' above.)

The management of TCH depends on the underlying etiology. (See 'Management' above.)

Use of UpToDate is subject to the Subscription and License Agreement.


  1. Day JW, Raskin NH. Thunderclap headache: symptom of unruptured cerebral aneurysm. Lancet 1986; 2:1247.
  2. Ducros A, Bousser MG. Thunderclap headache. BMJ 2013; 346:e8557.
  3. Broner S, Lay C, Newman L, Swerdlow M. Thunderclap headache as the presenting symptom of myocardial infarction. Headache 2007; 47:724.
  4. Evans RW. Thunderclap headache associated with a nonhemorrhagic anaplastic oligodendroglioma. MedGenMed 2007; 9:26.
  5. Mucchiut M, Valentinis L, Tuniz F, et al. Adult aqueductal stenosis presenting as a thunderclap headache: a case report. Cephalalgia 2007; 27:1171.
  6. Heo YE, Kwon HM, Nam HW. Thunderclap headache as an initial manifestation of phaeochromocytoma. Cephalalgia 2009; 29:388.
  7. Im SH, Kim NH. Thunderclap headache after micturition in bladder pheochromocytoma. Headache 2008; 48:965.
  8. Cho JH, Ahn JY, Byeon SH, Huh JS. Thunderclap headache as initial manifestation of Vogt-Koyanagi-Harada disease. Headache 2008; 48:153.
  9. Landtblom AM, Fridriksson S, Boivie J, et al. Sudden onset headache: a prospective study of features, incidence and causes. Cephalalgia 2002; 22:354.
  10. Markus HS. A prospective follow up of thunderclap headache mimicking subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1991; 54:1117.
  11. Linn FH, Rinkel GJ, Algra A, van Gijn J. Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J Neurol Neurosurg Psychiatry 1998; 65:791.
  12. Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000; 342:29.
  13. Kowalski RG, Claassen J, Kreiter KT, et al. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA 2004; 291:866.
  14. Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia 2003; 23:935.
  15. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146:34.
  16. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012; 11:906.
  17. Dodick DW, Brown RD Jr, Britton JW, Huston J 3rd. Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. Cephalalgia 1999; 19:118.
  18. Slivka A, Philbrook B. Clinical and angiographic features of thunderclap headache. Headache 1995; 35:1.
  19. Calabrese LH, Gragg LA, Furlan AJ. Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol 1993; 20:2046.
  20. Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum 2002; 47:662.
  21. Call GK, Fleming MC, Sealfon S, et al. Reversible cerebral segmental vasoconstriction. Stroke 1988; 19:1159.
  23. Schluter A, Kissig B. MR angiography in migrainous vasospasm. Neurology 2002; 59:1772.
  24. Farine D, Andreyko J, Lysikiewicz A, et al. Isolated angiitis of brain in pregnancy and puerperium. Obstet Gynecol 1984; 63:586.
  25. Janssens E, Hommel M, Mounier-Vehier F, et al. Postpartum cerebral angiopathy possibly due to bromocriptine therapy. Stroke 1995; 26:128.
  26. Henry PY, Larre P, Aupy M, et al. Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia 1984; 4:171.
  27. Meschia JF, Malkoff MD, Biller J. Reversible segmental cerebral arterial vasospasm and cerebral infarction: possible association with excessive use of sumatriptan and Midrin. Arch Neurol 1998; 55:712.
  28. Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002; 58:130.
  29. Levine SR, Washington JM, Jefferson MF, et al. "Crack" cocaine-associated stroke. Neurology 1987; 37:1849.
  30. Reneman L, Habraken JB, Majoie CB, et al. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol 2000; 21:1001.
  31. Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130:3091.
  32. Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011; 68:1005.
  33. Ducros A, Fiedler U, Porcher R, et al. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 2010; 41:2505.
  34. Sturm JW, Macdonell RA. Recurrent thunderclap headache associated with reversible intracerebral vasospasm causing stroke. Cephalalgia 2000; 20:132.
  35. Nowak DA, Rodiek SO, Henneken S, et al. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option? Cephalalgia 2003; 23:218.
  36. Dodick DW. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): the role of calcium antagonists. Cephalalgia 2003; 23:163.
  37. Lu SR, Liao YC, Fuh JL, et al. Nimodipine for treatment of primary thunderclap headache. Neurology 2004; 62:1414.
  38. Chen SP, Fuh JL, Lirng JF, et al. Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology 2006; 67:2164.
  39. Linn J, Fesl G, Ottomeyer C, et al. Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases? Cephalalgia 2011; 31:1074.
  40. de Bruijn SF, Stam J, Kappelle LJ. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet 1996; 348:1623.
  41. Cumurciuc R, Crassard I, Sarov M, et al. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry 2005; 76:1084.
  42. Rao KC, Knipp HC, Wagner EJ. Computed tomographic findings in cerebral sinus and venous thrombosis. Radiology 1981; 140:391.
  43. Chiras J, Bousser MG, Meder JF, et al. CT in cerebral thrombophlebitis. Neuroradiology 1985; 27:145.
  44. Mitsias P, Ramadan NM. Headache in ischemic cerebrovascular disease. Part I: Clinical features. Cephalalgia 1992; 12:269.
  45. Maruyama H, Nagoya H, Kato Y, et al. Spontaneous cervicocephalic arterial dissection with headache and neck pain as the only symptom. J Headache Pain 2012; 13:247.
  46. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.
  47. Rando TA, Fishman RA. Spontaneous intracranial hypotension: report of two cases and review of the literature. Neurology 1992; 42:481.
  48. Schievink WI, Wijdicks EF, Meyer FB, Sonntag VK. Spontaneous intracranial hypotension mimicking aneurysmal subarachnoid hemorrhage. Neurosurgery 2001; 48:513.
  49. Dodick DW, Wijdicks EF. Pituitary apoplexy presenting as a thunderclap headache. Neurology 1998; 50:1510.
  50. Embil JM, Kramer M, Kinnear S, Light RB. A blinding headache. Lancet 1997; 350:182.
  51. Schievink WI, Thompson RC, Loh CT, Maya MM. Spontaneous retroclival hematoma presenting as a thunderclap headache. Case report. J Neurosurg 2001; 95:522.
  52. Ferro JM, Melo TP, Oliveira V, et al. A multivariate study of headache associated with ischemic stroke. Headache 1995; 35:315.
  53. Vestergaard K, Andersen G, Nielsen MI, Jensen TS. Headache in stroke. Stroke 1993; 24:1621.
  54. Schwedt TJ, Dodick DW. Thunderclap stroke: embolic cerebellar infarcts presenting as thunderclap headache. Headache 2006; 46:520.
  55. Edvardsson BA, Persson S. Cerebral infarct presenting with thunderclap headache. J Headache Pain 2009; 10:207.
  56. Gossrau G, Dannenberg C, Reichmann H, Sabatowski R. [Thunderclap headache caused by cerebellar infarction]. Schmerz 2008; 22:82.
  57. Tang-Wai DF, Phan TG, Wijdicks EF. Hypertensive encephalopathy presenting with thunderclap headache. Headache 2001; 41:198.
  58. Dodick DW, Eross EJ, Drazkowski JF, Ingall TJ. Thunderclap headache associated with reversible vasospasm and posterior leukoencephalopathy syndrome. Cephalalgia 2003; 23:994.
  59. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996; 27:144.
  60. Healton EB, Brust JC, Feinfeld DA, Thomson GE. Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension. Neurology 1982; 32:127.
  61. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.
  62. Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992; 159:379.
  63. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 1998; 19:859.
  64. KELLY R. Colloid cysts of the third ventricle; analysis of twenty-nine cases. Brain 1951; 74:23.
  65. Michels LG, Rutz D. Colloid cysts of the third ventricle. A radiologic-pathologic correlation. Arch Neurol 1982; 39:640.
  66. Young WB, Silberstein SD. Paroxysmal headache caused by colloid cyst of the third ventricle: case report and review of the literature. Headache 1997; 37:15.
  67. Linn FH, Wijdicks EF, van der Graaf Y, et al. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet 1994; 344:590.
  68. McGeeney BE, Barest G, Grillone G. Thunderclap headache from complicated sinusitis. Headache 2006; 46:517.
  69. Linn FH. Primary thunderclap headache. Handb Clin Neurol 2010; 97:473.
  70. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33:629.
  71. ARMSTRONG FS, HAYES GJ. Segmental cerebral arterial constriction associated with pheochromocytoma: report of a case with arteriograms. J Neurosurg 1961; 18:843.
  72. Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988; 19:326.
  73. Margolis MT, Newton TH. Methamphetamine ("speed") arteritis. Neuroradiology 1971; 2:179.
  74. Kaye BR, Fainstat M. Cerebral vasculitis associated with cocaine abuse. JAMA 1987; 258:2104.
  75. Furlan JC. Headache attributed to autonomic dysreflexia: an underrecognized clinical entity. Neurology 2011; 77:792.
  76. Edvinsson L, Gulbenkian S, Barroso CP, et al. Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides 1998; 19:1213.
  77. Edvinsson, L, Owman, C. Cerebrovascular nerves and vasomotor receptors. In: Cerebral arterial spasm, Wilkins, RH (Ed), Williams and Wilkins, Baltimore 1980. p.30.
  78. Endo S, Suzuki J. Experimental cerebral vasospasm after subarachnoid hemorrhage. Participation of adrenergic nerves in cerebral vessel wall. Stroke 1979; 10:703.
  79. Edvinsson L, Egund N, Owman C, et al. Reduced noradrenaline uptake and retention in cerebrovascular nerves associated with angiographically visible vasoconstriction following experimental subarachnoid hemorrhage in rabbits. Brain Res Bull 1982; 9:799.
  80. van Gijn J, van Dongen KJ. The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology 1982; 23:153.
  81. Vermeulen M, Hasan D, Blijenberg BG, et al. Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry 1989; 52:826.
  82. Moussouttas M, Mayer SA. Thunderclap headache with normal CT and lumbar puncture: further investigations are unnecessary: against. Stroke 2008; 39:1394.
  83. Davis SM, Donnan GA. Thunderclap headache: CT and lumbar puncture but occasionally more! Stroke 2008; 39:1396.
  84. Savitz SI, Levitan EB, Wears R, Edlow JA. Pooled analysis of patients with thunderclap headache evaluated by CT and LP: is angiography necessary in patients with negative evaluations? J Neurol Sci 2009; 276:123.
  85. Wijdicks EF, Kerkhoff H, van Gijn J. Long-term follow-up of 71 patients with thunderclap headache mimicking subarachnoid haemorrhage. Lancet 1988; 2:68.
  86. Linn FH, Rinkel GJ, Algra A, van Gijn J. Follow-up of idiopathic thunderclap headache in general practice. J Neurol 1999; 246:946.
  87. Harling DW, Peatfield RC, Van Hille PT, Abbott RJ. Thunderclap headache: is it migraine? Cephalalgia 1989; 9:87.
  88. Landtblom, AM, Boivie, J, Fridriksson, S, et al. Thunderclap headache: final results from a prospective study of consecutive cases. Acta Neurol Scand 1996; 167 (Suppl 94):23.
  89. RAYNOR RB, ROSS G. Arteriography and vasospasm. The effects of intracarotid contrast media on vasospasm. J Neurosurg 1960; 17:1055.
  90. Warnock NG, Gandhi MR, Bergvall U, Powell T. Complications of intraarterial digital subtraction angiography in patients investigated for cerebral vascular disease. Br J Radiol 1993; 66:855.
  91. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain 2000; 123 ( Pt 2):205.
  92. Alberico RA, Patel M, Casey S, et al. Evaluation of the circle of Willis with three-dimensional CT angiography in patients with suspected intracranial aneurysms. AJNR Am J Neuroradiol 1995; 16:1571.
  93. Hope JK, Wilson JL, Thomson FJ. Three-dimensional CT angiography in the detection and characterization of intracranial berry aneurysms. AJNR Am J Neuroradiol 1996; 17:439.
  94. Schwedt TJ. Clinical spectrum of thunderclap headache. Expert Rev Neurother 2007; 7:1135.
Topic 3346 Version 5.0

Topic Outline



All topics are updated as new information becomes available. Our peer review process typically takes one to six weeks depending on the issue.